17 Result(s)
within
Chapter
Jian** **
English
Medicine/Public Health, general
Oncology
-
Chapter
Research and Development, Production, and Application Status of Quality Controls for in Vitro Diagnostic Reagents
As per requirements of ISO15189 Medical Laboratories-Requirements for Quality and Competence (2012), clinical laboratories providing medical laboratory services should meet the basic requirements of quality manag...
-
Chapter
Electrolyte Technologies
The solutes of human body fluids can be chemically divided into electrolytes and non-electrolytes. Electrolytes usually refer to potassium (K+), sodium (Na+), chloride (Cl−), calcium (Ca++), lithium (Li+), magnes...
-
Chapter
ELISA Immunological Reagents
Enzyme-linked immunosorbent assay (ELISA) has experienced vigorous development for nearly 50 years since it was proposed in 1971. At present, the common detection methods of ELISA immunoreagents include double...
-
Chapter
Tumor Markers
Tumor markers are substances that reflect the existence of tumors. They do not exist in normal adult tissues but only in embryonic tissues; their content in tumor tissues is much higher than in normal tissues....
-
Chapter
Clinical Chemistry Laboratory Automation
Total laboratory automation (TLA) refers to the integration of different testing platforms, pre-analysis, and post-analysis sample processing modules through automated transmission tracks and information netwo...
-
Chapter
Development and Application Status of National Reference Materials for in Vitro Diagnostic Reagents
In vitro diagnosis refers to the activity of analyzing and testing samples (blood, body fluids, tissues, etc.) taken from a human body by means of chemical, physical, or biological analysis, so as to evaluate ...
-
Chapter
Analysis of Blood Gas
Analysis of blood gas has recently been a rapidly developed medical inspection technique. At the end of the 1950s, Poul Astrup, a Danish physician, and chemist, developed the first blood gas analyzer. Since th...
-
Chapter
Investment, Financing, and Merger of Listed Companies in 2021
With the increasing trend of the aging population in China and the growth of per capita medical expenditure and technological progress, the growth rate of in vitro diagnostic (IVD) field in China has remained ...
-
Chapter
Performance of Listed Companies in 2021
After the initial period in the 1980s, the development period in 1990s, and the high-speed development period since the twenty-first century, the in vitro diagnostic (IVD) industry has grown into a complete ra...
-
Chapter
Urine
The major brands in China’s urinalysis market are URIT, DIRUI, AVE, etc. URIT produced China’s first urine analyzer in 1984. And after nearly 40 years’ strenuous cultivation, it pioneered the modular urine ana...
-
Chapter
Companion Diagnostics
Companion diagnostics (CDx), as a sub-field of in vitro diagnostics (IVD) industry, complements targeted therapy and is a necessary tool to achieve precision medicine. CDx mainly provides patients with the inf...
-
Chapter
Pancreatic Resection for Solid Pseudopapillary Neoplasms
Pancreatic solid pseudopapillary neoplasms (SPNs) are rare and relatively benign tumors, with a malignancy ratio of 10–15%. The utility of multiple imaging modalities, combining with age and gender profile, is...
-
Chapter
Stemness Regulation of Somatic Cancer Cells
Embryonic stem (ES) cells derive from the inner cell mass (ICM) of the blastocyst in early embryo stage, which lasts only a few days during the life. Soon after the blastocyst implants in endometrium, ICM cell...
-
Chapter
Validity of Markers for Epithelial Cells and Mesenchymal Cells
Stem cells are best known for their potential of differentiation. However, those so-called differentiated cells are not exactly lack of plasticity. This can be easily seen during wound healing, in which a lot ...
-
Chapter
Generation of Antigen-Specific T Lymphocytes from Induced Pluripotent Stem Cells for Adoptive Immunotherapy
Conquering cancer, one of the leading human health problems, is a major task for both basic and clinical scientists. With the understanding of recently developed cancer immunotherapy, in particular the cytotox...
-
Chapter
Marine Natural Products and their Synthetic Derivatives for Cancer Therapy
The ocean, which covers approximately 70% of the Earth’s surface, is a natural treasury of resources that houses about 80% of all the varieties of life on our planet. The past 20 years have seen a decrease in ...
-
Chapter
Mining Natural Product-Derived Molecules Against Cancer Targets: The Case of the Androgen Receptor in Prostate Cancer
Androgen receptor (AR) signaling is critical for prostate cancer progression. This has provided the rationale for the use of androgen ablation therapy, involving either surgical or chemical castration, to redu...
